SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-22-000041
Filing Date
2022-10-27
Accepted
2022-10-27 16:38:23
Documents
87
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20221027x10q.htm   iXBRL 10-Q 2461304
2 EX-10.1 tmb-20221027xex10d1.htm EX-10.1 20698
3 EX-10.2 tmb-20221027xex10d2.htm EX-10.2 15357
4 EX-31.1 tmb-20221027xex31d1.htm EX-31.1 10920
5 EX-31.2 tmb-20221027xex31d2.htm EX-31.2 10722
6 EX-32.1 tmb-20221027xex32d1.htm EX-32.1 5936
7 EX-32.2 tmb-20221027xex32d2.htm EX-32.2 6122
8 GRAPHIC tmb-20221027xex10d2001.jpg GRAPHIC 12244
  Complete submission text file 0001070081-22-000041.txt   12011317

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20221027.xsd EX-101.SCH 74724
10 EX-101.CAL tmb-20221027_cal.xml EX-101.CAL 76625
11 EX-101.DEF tmb-20221027_def.xml EX-101.DEF 397808
12 EX-101.LAB tmb-20221027_lab.xml EX-101.LAB 757289
13 EX-101.PRE tmb-20221027_pre.xml EX-101.PRE 607136
81 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221027x10q_htm.xml XML 2413651
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 221337814
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences